Cargando…
Statin-induced LDL cholesterol response and type 2 diabetes: a bidirectional two-sample Mendelian randomization study
It remains unclear whether the increased risk of new-onset type 2 diabetes (T2D) seen in statin users is due to low LDL-C concentrations, or due to the statin-induced proportional change in LDL-C. In addition, genetic instruments have not been proposed before to examine whether liability to T2D migh...
Autores principales: | Smit, Roelof AJ, Trompet, Stella, Leong, Aaron, Goodarzi, Mark O, Postmus, Iris, Warren, Helen, Theusch, Elizabeth, Barnes, Michael R, Arsenault, Benoit J, Li, Xiaohui, Feng, QiPing, Chasman, Daniel I, Cupples, L Adrienne, Hitman, Graham A, Krauss, Ronald M, Psaty, Bruce M, Rotter, Jerome I, le Cessie, Saskia, Stein, C Michael, Jukema, J Wouter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260089/ https://www.ncbi.nlm.nih.gov/pubmed/31801993 http://dx.doi.org/10.1038/s41397-019-0125-x |
Ejemplares similares
-
The Pharmacogenetics of Statin Therapy on Clinical Events: No Evidence that Genetic Variation Affects Statin Response on Myocardial Infarction
por: Trompet, Stella, et al.
Publicado: (2022) -
Survival Bias in Mendelian Randomization Studies: A Threat to Causal Inference
por: Smit, Roelof A. J., et al.
Publicado: (2019) -
Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation
por: Kim, Kyungpil, et al.
Publicado: (2014) -
Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses
por: Trompet, Stella, et al.
Publicado: (2011) -
ZNF542P is a pseudogene associated with LDL response to simvastatin treatment
por: Kim, Kyungpil, et al.
Publicado: (2018)